Rudy Tanzi, Ph.D., talks to CuriosityStream about the basics of Alzheimer's disease. Tanzi describes how the disease affects the brain on a cellular level and how these changes produce the symptoms we observe in Alzheimer's patients.
A recent study by researchers at the University of Virginia suggests previously unknown links between the body's immune system and the brain. According to Cure Alzheimer's Fund Research Consortium chairman Dr. Rudy Tanzi, these findings could be "absolutely game-changing" in the field of Alzheimer's research once confirmed.
Rudy Tanzi, Ph.D., professor of neurology at Harvard Medical School, presents “Ending Alzheimer’s in Our Lifetime: From Genes to Therapies” on July 10, 2014 at the Martha’s Vineyard Hebrew Center’s Summer Institute.
At its core, Alzheimer’s is a disease that disrupts communications between neurons (nerve cells) in the brain, and ultimately kills those neurons. Cure Alzheimer’s Fund has committed to understanding this destructive process as a necessary component to stopping the disease. To that end, it has recruited four of the world’s top experts in the field: University of California, San Diego’s Roberto Malinow, Stanford’s Robert Malenka and Thomas Südhof, and Rick Huganir at Johns Hopkins.